- Q1 2024 Bolt Biotherapeutics Inc Earnings Call TranscriptMay 14, 2024$1.32 (-0.75%)Earnings
- Bolt Biotherapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Bolt Biotherapeutics Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- Bolt Biotherapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 16, 2023
- Bolt Biotherapeutics Inc at Guggenheim Healthcare Talks Oncology Day TranscriptFeb 08, 2023
- Bolt Biotherapeutics Inc at Stifel Healthcare Conference TranscriptNov 16, 2022
- Bolt Biotherapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Bolt Biotherapeutics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 14, 2022
- Bolt Biotherapeutics Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 09, 2022
- Bolt Biotherapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Bolt Biotherapeutics Inc CMC Considerations For In-Human Studies with Drs. Edith Perez And Nathan Ihle TranscriptSep 23, 2020
Q1 2024 Bolt Biotherapeutics Inc Earnings Call Transcript
Good afternoon and welcome to the Bolt biotherapeutics Strategic Update Conference Call. (Operator Instructions) As reminder, this call may be recorded.
I would now like to hand the call over to Willie Quinn, Chief Executive Officer of both both biotherapeutics. Please go ahead, sir.
Thank you, and good afternoon, everyone. This afternoon, we issued our first quarter 2024 financial results and business update, which outlines the topics we plan to discuss today. You can access the press release by going to the Investors and Media section of our website at www.boltbio.com.
I am joined today by Randy Schatzman, outgoing Chief Executive Officer, and Edith Perez outgoing Chief Medical Officer. I am also joined by some newly promoted members of both senior leadership team, including Michael Alonso, so Co-Founder of Bolt and newly promoted Senior Vice President of Research, and Dawn Colburn, newly promoted Senior Vice
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)